Projects per year
Personal profile
Education
- 2013.06-2015.06 M.S., College of Management, National Taiwan University
- 1997.09-2002.01 Ph.D., Taipei Medical University
- 1979.09-1986.06 M.D., School of Medicine, Taipei Medical College
Experience
- 2020.04-2022.09 Vice superintendent, Taipei Municipal Wanfang Hospital
- 2019.01-2020.03 Vice superintendent, Taipei Medical University Hospital
- 2016.08- Professor, Executive Master Program of Business Administration in Biotechnology, College of Management, Taipei Medical University
- 2016.02-2018.12 Dean of Research and Development, Office of Research and Development, Taipei Medical University
- 2013.09 Vice Dean, College of Medicine, Taipei Medical University
- 2013.08-2013.08 Acting Dean, College of Medicine, Taipei Medical University
- 2011.05 Director, School of Medicine, Taipei Medical University
- 2011.01-2011.01 Acting Director, School of Medicine, Taipei Medical University
- 2010.02- Professor, General Medicine, School of Medicine, Taipei Medical University
- 2010.02-2011.08 Deputy Account Director, School of Medicine, Taipei Medical University
- 2009.08-2010.01 Professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2008.06-2011.06 Vice superintendent, Taipei Medical University Hospital
- 2007.08- Associate Professor, Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2007.02 Director, Department of primary care medicine, Taipei Medical University Hospital
- 2005.08-2009.07 Associate Professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2002.02-2005.07 Assistant Professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 1998.07-2002.01 Instructor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 1997.10-1999.07 Attending Physician, Taipei Medical University Hospital
- 1994.03-1997.09 Attending Physician, Taipei City Hospital Renai Branch
- 1988.07-1994.02 Resident Physician, Taipei City Hospital Renai Branch
Awards
- Consultant, Gastroenterolgical Society of Taiwan
- Consultant, Digestive Endoscopic Society of Taiwan
Research Interests
- Gastroenterology
- GI tract cancer molecular medicine
Fingerprint
- 1 Similar Profiles
Network
-
Development of an Anti-Egfr/Anti-Cd3/Anti-Mpeg Trispecific Antibody to Synergistically Enhance the Anti-Cancer Efficacy of Immuno-Enhancing Drug-Loaded Mpeg-Nanocarriers and T Cells in Tumor Microenvironment of Colorectal Cancer( III )
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Development of Anti-Cd3 Targeted Immunoadjuvant-Liposome Fused with Dendritic Cells-Derived Exosomes for Colon Cancer Immunotherapy
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
-
發展三功能抗體(EGFR/CD3/mPEG)修飾之聚乙二醇-免疫增敏奈米藥物以主動標靶毒殺大腸癌並同時強化體內T細胞於腫瘤微環境抗癌功效之創新協同療法-開發三功能抗體(EGFR/CD3/mPEG)以協同加成聚乙二醇-免疫增敏奈米藥物及T細胞於大腸癌腫瘤微環境之抗癌功效(2/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
以CD3標靶微脂粒包覆免疫佐劑結合樹突狀細胞之胞外泌體應用於大腸癌免疫治療(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
Synergistic Combination of Irinotecan and Rapamycin Orally Delivered by Nanoemulsion for Enhancing Therapeutic Efficacy of Pancreatic Cancer
Liu, Y. H., Chen, L. C., Cheng, W. T., Wei, P. S., Hsieh, C. M., Sheu, M. T., Lin, S. Y., Ho, H. O. & Lin, H. L., Feb 2023, In: Pharmaceutics. 15, 2, 473.Research output: Contribution to journal › Article › peer-review
Open Access -
A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor
Chen, M., Sheu, M. T., Cheng, T. L., Roffler, S. R., Lin, S. Y., Chen, Y. J., Cheng, Y. A., Cheng, J. J., Chang, H. Y., Wu, T. Y., Kao, A. P., Ho, Y. S. & Chuang, K. H., Jan 7 2022, In: Biomaterials Science. 10, 1, p. 202-215 14 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Bispecific T-cell engagers non-covalently decorated drug-loaded PEGylated nanocarriers for cancer immunochemotherapy
Cheng, W. J., Chuang, K. H., Lo, Y. J., Chen, M., Chen, Y. J., Roffler, S. R., Ho, H. O., Lin, S. Y. & Sheu, M. T., Apr 2022, In: Journal of Controlled Release. 344, p. 235-248 14 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Combined Docetaxel/Pictilisib-Loaded mPEGylated Nanocarriers with Dual HER2 Targeting Antibodies for Synergistic Chemotherapy of Breast Cancer
Cheng, W. J., Lin, S. Y., Chuang, K. H., Chen, M., Ho, H. O., Chen, L. C., Hsieh, C. M. & Sheu, M. T., 2022, In: International Journal of Nanomedicine. 17, p. 5353-5374 22 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Controlled Decomposable Hydrogel Triggered with a Specific Enzyme
Ji, Y. R., Hsu, Y. H., Syue, M. H., Wang, Y. C., Lin, S. Y., Huang, T. W. & Young, T. H., Feb 1 2022, In: ACS Omega. 7, 4, p. 3254-3261 8 p.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Additional file 1 of Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit
Lee, Y. (Creator), Lin, H. (Creator), Lin, S. (Creator), Chen, J. (Creator), Fang, C. (Creator), Liu, H. (Creator), Lin, H. (Creator) & Hsueh, P. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.15095395.v1, https://doi.org/10.6084%2Fm9.figshare.15095395.v1
Dataset
-
Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit
Lee, Y. (Creator), Chen, J. (Creator), Lin, H. (Creator), Liu, H. (Creator), Lin, S. (Creator), Lin, H. (Creator), Fang, C. (Creator) & Hsueh, P. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5540209.v1, https://springernature.figshare.com/collections/Impact_of_active_screening_for_methicillin-resistant_Staphylococcus_aureus_MRSA_and_decolonization_on_MRSA_infections_mortality_and_medical_cost_a_quasi-experimental_study_in_surgical_intensive_care_unit/5540209/1
Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Chen, L. (Contributor), Lin, S. (Contributor), Sheu, M. (Contributor), Ho, Y. (Contributor), Su, C. (Contributor), Chen, M. (Contributor), Ho, H. (Contributor) & Chuang, K. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.6213620, https://doi.org/10.6084%2Fm9.figshare.6213620
Dataset
-
Data from: Primary Sjogren’s syndrome and the risk of acute pancreatitis: a nationwide cohort study
Chang, C. (Contributor), Chang, Y. (Contributor), Wang, S. (Contributor), Lin, S. (Contributor), Chen, Y. (Contributor) & Chen, J. (Contributor), Unknown Publisher, Aug 1 2017
DOI: 10.5061/dryad.22h7c, http://datadryad.org/stash/dataset/doi:10.5061/dryad.22h7c
Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C. (Contributor), Chen, M. (Contributor), Chen, L. (Contributor), Ho, Y. (Contributor), Ho, H. (Contributor), Lin, S. (Contributor), Chuang, K. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, May 2 2018
DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1
Dataset